- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | What Happens at $200 a Barrel? | ||
| Fr | Ollie's Bargain Q4 Earnings Beat Estimates, Comps Rise 3.6% Y/Y | ||
| Fr | Repsol Signs Strategic Deals With Venezuela to Boost Gas Production | ||
| Fr | Rising LNG Exports & AI-Driven Power Demand Drive Growth for Archrock | ||
| Fr | Equinor Flags Production Limits Amid Global Energy Supply Shortage | ||
| Fr | Chubb's Solid Growth Comes With a Premium Valuation - Hold or Buy? | ||
| Fr | Cigna Stock Trades Below Industry P/E: Is It Worth Holding Now? | ||
| Fr | TRV Stock Up 4% YTD, Trades at 2.05X P/B: What Should Investors Know? | ||
| Fr | 3 Dividend Aristocrats to Buy Now Amid the Middle East Crisis | ||
| Fr | Is PATH Stock a Hold After Q4 Beat, Buybacks, and Margin Gains? | ||
| Fr | UiPath and Unified Automation: What's Driving ARR Growth | ||
| Fr | MKSI Gets SBTi Approval for 2030 Science-Based Emission Targets | ||
| Fr | AWR Gains From Investment & Rising Demand as Customer Base Expands | ||
| Fr | Nu Holdings Turns Expanding Customer Base Into Profitable Growth | ||
| Fr | Quantum Computing Set to Scale in 2026: IONQ, QBTS, RGTI's Outlook | ||
| Fr | Berkshire vs. Allstate: Which Insurance Leader Is the Better Pick? | ||
| Fr | Here's How the Test Systems Segment Powers Astronics' Growth Story | ||
| Fr | PATH Delivers Strong Quarter to Close its Fiscal Year: Is PATH a Buy? | ||
| Fr | IBRX and the BCG Shortage: A 2026 Catalyst Investors Are Tracking | ||
| Fr | ImmunityBio Valuation: Paying 33x Sales for Anktiva | ||
| Fr | IBRX Stock: Anktiva's Approvals and What Comes Next | ||
| Fr | Amkor Eyes Strong Second Half 2026 as AI, HPC Packaging Demand Surges | ||
| Fr | Oracle: The AI Darkhorse? | ||
| Fr | CRH and the Data Center Buildout: What Investors Miss | ||
| Fr | Lennar's Q1 Earnings & Revenues Miss, New Home Orders Up Y/Y |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.